CY150112
/ Jiangsu NHWA Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 09, 2021
A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects
(clinicaltrials.gov)
- P1; N=60; Recruiting; Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd.
New P1 trial • CNS Disorders • Psychiatry • Schizophrenia
1 to 1
Of
1
Go to page
1